within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AF08_AdefovirDipivoxil;

model AdefovirDipivoxil
  extends Pharmacolibrary.Drugs.ATC.J.J05AF08;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J05AF08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Adefovir dipivoxil is an oral nucleotide analog reverse transcriptase inhibitor formerly approved for the treatment of chronic hepatitis B virus (HBV) infection in adults. Due to risk of nephrotoxicity and availability of more effective treatments, its use has been largely discontinued in favor of safer alternatives. It works by inhibiting HBV polymerase, suppressing viral replication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult male and female volunteers after oral administration. Parameters are based on published clinical pharmacokinetic studies.</p><h4>References</h4><ol><li><p>Noble, S, &amp; Goa, KL (1999). Adefovir dipivoxil. <i>Drugs</i> 58(3) 479–489. DOI:<a href=&quot;https://doi.org/10.2165/00003495-199958030-00010&quot;>10.2165/00003495-199958030-00010</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10493275/&quot;>https://pubmed.ncbi.nlm.nih.gov/10493275</a></p></li><li><p>Huang, J, et al., &amp; Zheng, Q (2014). Population pharmacokinetics of adefovir dipivoxil tablets in healthy Chinese volunteers. <i>International journal of clinical pharmacology and therapeutics</i> 52(1) 8–14. DOI:<a href=&quot;https://doi.org/10.5414/CP201928&quot;>10.5414/CP201928</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24219967/&quot;>https://pubmed.ncbi.nlm.nih.gov/24219967</a></p></li><li><p>Cullen, JM, et al., &amp; Gibbs, C (2001). Antiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks. <i>Antimicrobial agents and chemotherapy</i> 45(10) 2740–2745. DOI:<a href=&quot;https://doi.org/10.1128/AAC.45.10.2740-2745.2001&quot;>10.1128/AAC.45.10.2740-2745.2001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11557463/&quot;>https://pubmed.ncbi.nlm.nih.gov/11557463</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end AdefovirDipivoxil;
